Rankiteo Logo
Rankiteo
Leader in Cyber Underwriting
Loading...
NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop
WindowsmacOSLinux
Download

Comparison Overview

GrifolsGrifols
VS
Intas PharmaceuticalsIntas Pharmaceuticals
Grifols

Grifols

Parc Empresarial Can Sant Joan, Sant Cugat del Vallès, 08174, ES

Last Update: 07/09/2026

View Profile
Between 750 and 799
https://linktr.ee/Grifols
771/1000Fair

Grifols is a global healthcare company founded in Barcelona in 1909 committed to improving the health and well-being of people all over the world. A leader in essential plasma-derived medicines and transfusion medicine, we develop, produce and provide innovative healt...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:13,839
Subsidiaries:4
12-month incidents
0
Known data breaches
0
Attack type number
0
Intas Pharmaceuticals

Intas Pharmaceuticals

Sarkhej Gandhinagar Highway, Near Sola Bridge, Ahmedabad, Gujarat, IN

Last Update: 18/09/2026

View Profile
Between 750 and 799
https://intaspharma.com
795/1000Fair

Intas is one of the leading multinational pharmaceutical formulation development, manufacturing, and marketing organization in the world. It has been growing at 19% CAGR and crossed the $2.5 billion mark in the past financial year. The company has set up a network of su...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:18,773
Subsidiaries:1
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Ranges Comparison

Based On Specific Ai Models Category
Grifols

Grifols

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA
Intas Pharmaceuticals

Intas Pharmaceuticals

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA

Benchmark & Cyber Underwriting Signals

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Grifols in 2026.

Incidents

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Intas Pharmaceuticals in 2026.

Incidents

Incident History - Grifols (X = Date, Y = Severity)

Grifols cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Incident History - Intas Pharmaceuticals (X = Date, Y = Severity)

Intas Pharmaceuticals cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Notable Incidents

Last Cyber / HR Incidents / Global...
Grifols

Grifols

Incidents
No explicit notable incidents reported.
Intas Pharmaceuticals

Intas Pharmaceuticals

Incidents
No explicit notable incidents reported.

FAQ

Between Grifols company and Intas Pharmaceuticals company, which one has the best AI Cybersecurity Score ?
Between Grifols company and Intas Pharmaceuticals company, which one has experienced more cyber incidents in the past ?
Between Grifols company and Intas Pharmaceuticals company, which one has experienced more cyber incidents this year ?
Between Grifols company and Intas Pharmaceuticals company, which one has experienced at least one ransomware attack ?
Between Grifols company and Intas Pharmaceuticals company, which one has experienced at least one data breach ?
Between Grifols company and Intas Pharmaceuticals company, which one has experienced at least one targeted cyberattack ?
Between Grifols company and Intas Pharmaceuticals company, which one has experienced at least one vulnerability ?
Between Grifols company and Intas Pharmaceuticals company, which one holds the most compliance certifications ?
Between Grifols company and Intas Pharmaceuticals company, which one holds the fewest compliance certifications ?
Between Grifols company and Intas Pharmaceuticals company, which one has the most subsidiaries ?
Between Grifols company and Intas Pharmaceuticals company, which one has the largest number of employees ?
Between Grifols and Intas Pharmaceuticals, which company holds both SOC 2 Type 1 certifications ?
Between Grifols and Intas Pharmaceuticals, which company holds both SOC 2 Type 2 certifications ?
Which company is ISO 27001 certified - Grifols or Intas Pharmaceuticals ?
Which company is PCI DSS compliant - Grifols or Intas Pharmaceuticals ?
Between Grifols and Intas Pharmaceuticals, which company complies with HIPAA regulations for healthcare data ?
Between Grifols and Intas Pharmaceuticals, which company complies with GDPR requirements ?

Latest Global CVEs

CVE-2026-94426
SUMMARY

A vulnerability was determined in xuxueli xxl-job up to 3.5.0. The impacted element is an unknown function of the file /jobgroup/insert. This manipulation of the argument Name causes cross site scripting. The attack can be initiated remotely. The exploit has been publicly disclosed and may be utilized. The vendor was contacted early about this disclosure but did not respond in any way.

PUBLISHED
Date2026-09-21
UPDATED
Date2026-09-21
RISK INFORMATION (Score: 3.5)
CVSS2
Base Score: 4.0
Complexity: LOW
AV:N/AC:L/Au:S/C:N/I:P/A:N
CVSS3
Base Score: 3.5
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:U/C:N/I:L/A:N
CVSS4
Base Score: 2.0
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:P/VC:N/VI:L/VA:N/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
1.4
EXPLOITABILITY
2.1
CVE-2026-94425
SUMMARY

A vulnerability was found in Moore Threads MTT S80 Driver Package 340.150. The affected element is the function sub_140006F0C in the library mtdispkm64.sys of the component IOCTL Handler. The manipulation results in improper privilege management. Attacking locally is a requirement. The vendor was contacted early about this disclosure but did not respond in any way.

PUBLISHED
Date2026-09-21
UPDATED
Date2026-09-21
RISK INFORMATION (Score: 8.8)
CVSS2
Base Score: 6.8
Complexity: LOW
AV:L/AC:L/Au:S/C:C/I:C/A:C
CVSS3
Base Score: 8.8
Complexity: LOW
CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:C/C:H/I:H/A:H
CVSS4
Base Score: 9.3
Complexity: LOW
CVSS:4.0/AV:L/AC:L/AT:N/PR:L/UI:N/VC:H/VI:H/VA:H/SC:H/SI:H/SA:H/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
6
EXPLOITABILITY
2
CVE-2026-94627
SUMMARY

vLLM Mooncake connector through 0.29.0 fails to properly manage GPU KV cache block ownership when concurrent child requests share a single transfer ID in prefill/decode disaggregated deployments. Attackers can trigger GPU memory exhaustion by submitting completion requests with multiple prompts, causing orphaned KV cache blocks to accumulate until process restart and eventually preventing legitimate requests from executing.

PUBLISHED
Date2026-09-21
UPDATED
Date2026-09-21
RISK INFORMATION (Score: 7.5)
CVSS3
Base Score: 7.5
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H
CVSS4
Base Score: 8.7
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:N/VI:N/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
3.6
EXPLOITABILITY
3.9
CVE-2026-94626
SUMMARY

vLLM through 0.29.0 fails to validate the tp_size parameter in kv_transfer_params on OpenAI-compatible completion endpoints, allowing attackers to allocate unbounded memory. Attackers can supply arbitrary tp_size values in prefill/decode disaggregated deployments to exhaust memory and trigger kernel OOM-kill of the decode worker process.

PUBLISHED
Date2026-09-21
UPDATED
Date2026-09-21
RISK INFORMATION (Score: 7.5)
CVSS3
Base Score: 7.5
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H
CVSS4
Base Score: 8.7
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:N/VI:N/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
3.6
EXPLOITABILITY
3.9
CVE-2026-94625
SUMMARY

vLLM through 0.29.0 contains a resource exhaustion vulnerability in MooncakeConnector where rejected prefill requests create ownerless transfer placeholders that are never reclaimed. Attackers can send rejected requests to exhaust sender task pools, causing valid requests to be delayed by up to 480 seconds while health checks continue returning success.

PUBLISHED
Date2026-09-21
UPDATED
Date2026-09-21
RISK INFORMATION (Score: 5.3)
CVSS3
Base Score: 5.3
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:L
CVSS4
Base Score: 6.9
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:N/VI:N/VA:L/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
1.4
EXPLOITABILITY
3.9